- Home
- KMI vs XOMAP Comparison
KMI vs XOMAP Comparison
Compare KMI & XOMAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMI
- XOMAP
- Stock Information
- Founded
- KMI 1936
- XOMAP N/A
- Country
- KMI United States
- XOMAP United States
- Employees
- KMI N/A
- XOMAP 13
- Industry
- KMI Natural Gas Distribution
- XOMAP Biotechnology: Pharmaceutical Preparations
- Sector
- KMI Utilities
- XOMAP Health Care
- Exchange
- KMI Nasdaq
- XOMAP Nasdaq
- Market Cap
- KMI 52.4B
- XOMAP N/A
- IPO Year
- KMI 2011
- XOMAP N/A
- Fundamental
- Price
- KMI $24.82
- XOMAP $26.47
- Analyst Decision
- KMI Buy
- XOMAP
- Analyst Count
- KMI 13
- XOMAP 0
- Target Price
- KMI $24.92
- XOMAP N/A
- AVG Volume (30 Days)
- KMI 14.3M
- XOMAP N/A
- Earning Date
- KMI 10-16-2024
- XOMAP N/A
- Dividend Yield
- KMI 4.63%
- XOMAP N/A
- EPS Growth
- KMI 3.81
- XOMAP N/A
- EPS
- KMI 1.13
- XOMAP N/A
- Revenue
- KMI $15,151,000,000.00
- XOMAP N/A
- Revenue This Year
- KMI $3.78
- XOMAP N/A
- Revenue Next Year
- KMI $4.96
- XOMAP N/A
- P/E Ratio
- KMI $21.90
- XOMAP N/A
- Revenue Growth
- KMI N/A
- XOMAP N/A
- 52 Week Low
- KMI $15.91
- XOMAP N/A
- 52 Week High
- KMI $25.43
- XOMAP N/A
- Technical
- Relative Strength Index (RSI)
- KMI 74.01
- XOMAP 64.62
- Support Level
- KMI $24.50
- XOMAP $26.24
- Resistance Level
- KMI $25.01
- XOMAP $26.48
- Average True Range (ATR)
- KMI 0.48
- XOMAP 0.14
- MACD
- KMI 0.06
- XOMAP 0.03
- Stochastic Oscillator
- KMI 76.89
- XOMAP 99.03
About KMI Kinder Morgan Inc.
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 82,000 miles in pipelines and 139 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.